Fractyl Health to Participate in the Upcoming December Conferences
Fractyl Health to Participate in the Upcoming December Conferences
Format: Fireside ChatBURLINGTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will present at two upcoming investor conferences.
美国马萨诸塞州伯灵顿，2024年11月26日（环球通讯社） -- Fractyl Health, Inc.（纳斯达克：GUTS）（"公司"），一家专注于开创性治疗肥胖和2型糖尿病（T2D）根本原因的新方法的代谢治疗公司，今天宣布公司的联合创始人兼首席执行官Harith Rajagopalan万. D., Ph.D.将参加即将举行的两场投资者会议。
Details of the presentations can be found below.
演示的详细信息如下。
7th Annual Evercore ISI HealthCONx Conference
第7届Evercore ISI HealthCONx会议
Format: Fireside Chat
格式：炉边聊天
Date: 12/03/2024
日期：2024年12月03日
Time: 7:30 AM ET
时间：东部时间上午7:30
Piper Sandler 36th Annual Healthcare Conference
派杰投资第36届医疗保健年会
Format: Fireside Chat
格式：炉边聊天
Date: 12/04/2024
日期：2024年12月04日
Time: 1:30 PM ET
时间：东部时间下午1:30
Webcast replays will be accessible following the live sessions on the Events page of the Investors section on the Company's website at .
网络直播重播将在公司网站的投资者部分的事件页面上提供。
About Fractyl Health
Fractyl Health是一家代谢治疗公司，重点是创新糖代谢疾病的治疗方法，包括肥胖和T2D。尽管过去50年治疗方法得到了进步，但肥胖和T2D在21世纪仍然是快速增长的死亡和发病因素。Fractyl Health的目标是将代谢性疾病治疗从慢性症状管理转变为可持久的治疗疾病的疗法，着重于针对疾病的根本原因。Fractyl Health总部位于马萨诸塞州伯灵顿。欲了解更多信息，请访问网站或。
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health's goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit .
Fractyl Health是一家代谢治疗公司，专注于开拓治疗代谢性疾病，包括肥胖和T2D的新方法。尽管在过去50年里治疗方面取得了进展，但肥胖和T2D仍然是21世纪快速增长的致病率和死亡率驱动因素。Fractyl Health的目标是将代谢性疾病治疗从慢性症状管理转变为持久性疾病修饰疗法，针对疾病的器官水平根本原因。Fractyl Health总部位于马萨诸塞州的伯灵顿。欲了解更多信息，请访问。
Contacts
联系人
Corporate Contact
Lisa Davidson, Chief Financial Officer
ir@fractyl.com, 781.902.8800
公司联系方式
Lisa Davidson, 致富金融(临时代码) 首席财务官
ir@fractyl.com，781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com, 978.760.5622
媒体联系人
Jessica Cotrone，企业传播
jcotrone@fractyl.com, 978.760.5622
Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681
投资者联系人
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681
